Low-dose prostacyclin has potent capillary permeability-reducing effect in cat skeletal muscle in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 1 42-1, 1997, Pages

  Möller, Alma D ^a,b   Grände, Per Olof ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Dept of Physiology and Neuroscience ^*  (Sweden)

Author keywords

Bradykinin; Capillary filtration coefficient; Histamine; Indomethacin; Tumor necrosis factor

Indexed keywords

BRADYKININ; HISTAMINE; INDOMETACIN; PROSTACYCLIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CAT; DOSE RESPONSE; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 33751275021     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.1.h200     Document Type: Article

References (38)

1. Babe, Jr., K. S., and W. E. Serafin. Histamine, bradykinin, and their antagonists. In: The Pharmacological Basis of Therapeutics, edited by J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. Goodman Gilman. New York: McGraw-Hill, 1996, p. 581-600.
2. Beijer, L., J. Botting, P. Crook, A. O. Oyekan, C. P. Page, and R. Rylander. The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea pig. Br. J. Pharmacol. 92: 803-808, 1987.
3. Blebea, J., R. A. Cambria, D. DeFouw, R. N. Feinberg, R. W. Hobson II, and W. N. Duran. Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion. J. Vasc. Surg. 12: 657-666, 1990.
4. Busse, R., M. Hecker, and, I. Fleming. Control of nitric oxide and prostacyclin synthesis in endothelial cells. Arzneim. Forsch. Drug Res. 44: 392-396, 1994.
5. Casnocha, S. A., S. G. Eskin, E. R. Hall, and L. V. McIntire. Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. J. Appl. Physiol. 67: 1997-2005, 1989.
6. 2-activating protein in endothelial cells. Biochem. J. 250: 125-132, 1988.
7. 2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br. J. Pharmacol. 96: 920-926, 1989.
8. Dubose, D. A., D. Shepro, and H. B. Hechtman. Correlation among endothelial cell shape, F-actin arrangement, and prostacyclin synthesis. Life Sci. 40: 447-453, 1986.
9. Erlandsson, M., D. Bergqvist, N. H. Persson, and E. Svensjö. Modification of postischemic increase of leukocyte adhesion and vascular permeability in the hamster by iloprost. Prostaglandins 41: 157-168, 1991.
10. Folkow, B., and S. Mellander. Measurements of capillary filtration coefficient and its use in studies of the control of capillary exchange. In: Capillary Permeability: The Transfer of Molecules and Ions Between Capillary Blood and Tissue, edited by C. Crone and N. A. Lassen. Copenhagen: Munksgaard, 1970, p. 614-623.
11. Gorman, R. R., S. Bunting, and O. V. Miller. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377-388, 1977.
12. Grega, G. J., and S. W. Adamski. The role of venular endothelial cells in the regulation of macromolecular permeability. Microcirc. Endothelium Lymphatics 4: 143-167, 1988.
13. Gryglewski, R. J., R. M. Botting, and J. R. Vane. Mediators produced by the endothelial cell. Hypertension 12: 530-548, 1988.
14. Grände, P.-O. Influence of neural and humoral beta-adrenoceptor stimulation on dynamic myogenic microvascular reactivity in cat skeletal muscle. Acta Physiol. Scand. 106: 457-465, 1979.
15. 2 on increased lung vascular permeability caused by endotoxin in dogs. Nippon Kyobu Shikkan Gakkai Zasshi 16: 410-417, 1978.
16. Jahr, J., U. Ekelund, and P.-O. Grände. In vivo effects of prostacyclin on segmental vascular resistances, on myogenic reactivity, and on capillary fluid exchange in cat skeletal muscle. Crit. Care Med. 23: 523-531, 1995.
17. Jahr, J., and P.-O. Grände. Prostacyclin counteracts the increase in capillary permeability induced by tumor necrosis factor-α. Intensive Care Med. 22: 1453-1460, 1996.
18. Jones, G., and J. V. Hurley. The effect of prostacyclin on the adhesion of leukocytes to injured vascular endothelium. J. Pathol. 142: 51-59, 1984.
19. Killackey, J. J. F., M. G. Johnston, and H. Z. Movat. Increased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin. A model for the in vitro study of increased vasopermeability. Am. J. Pathol. 122: 50-61, 1986.
20. Lewis, P. J., and C. T. Dollery. Clinical pharmacology and potential of prostacyclin. Br. Med. Bull. 39: 281-284, 1983.
21. Manjo, G., V. Gilmore, and M. Leventhal. On the mechanism of vascular leakage caused by histamine-type mediators. A microscopic study in vivo. Circ. Res. XXI: 833-847, 1967.
22. Moncada, S., R. Gryglewski, S. Bunting, and J. R. Vane. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976.
23. 2 and prostacyclin. Pharmacol. Rev. 30: 293-331, 1979.
24. Morel, N. M. L., P. P. Petruzzo, H. B. Hechtman, and D. Shepro. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction. Inflammation 14: 571-583, 1990.
25. Müller, B., M. Schmidtke, and W. Witt. Action of the stable prostacyclin analogue iloprost on microvascular tone and permeability in the hamster cheek pouch. Prostaglandins Leukot. Med. 29: 187-198, 1987.
26. Oliver, J. A. Adenylate cyclase and protein kinase C mediate opposite actions on endothelial junctions. J. Cell. Physiol. 145: 536-542, 1990.
27. Oliver, J. A. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J. Cell. Physiol. 151: 506-511, 1992.
28. Pappenheimer, J. R., and A. Soto-Rivera. Effective osmotic pressure of the plasma proteins and other quantities associated with the capillary circulation in the hindlimbs of cats and dogs. Am. J. Physiol. 152: 471-491, 1948.
29. Radomski, M. W., R. M. J. Palmer, and S. Moncada. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92: 639-646, 1987.
30. Rampart, M., and T. J. Williams. Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. Am. J. Pathol. 124: 66-73, 1986.
31. Rippe, B., and G. J. Grega. Effects of isoprenaline and cooling on histamine induced changes of capillary permeability in the rat hindquarter vascular bed. Acta Physiol. Scand. 103: 252-262, 1978.
32. Royall, J. A., R. L. Berkow, J. S. Beckman, M. K. Cunningham, S. Matalon, and B. A. Freeman. Tumor necrosis factor and interleukin 1α increase vascular endothelial permeability. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L399-L410, 1989.
33. Rumbaut, R. E., M. K. McKay, and V. H. Huxley. Capillary hydraulic conductivity is decreased by nitric oxide synthase inhibition. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1856-H1861, 1995.
34. Tracey, K. J., and A. Cerami. Tumor necrosis factor: an updated review of its biology. Crit. Care Med. 21: S415-S422, 1993.
35. Vane, J. R., and R. M. Botting. Pharmacodynamic profile of prostacyclin. Am. J. Cardiol. 75: 3A-10A, 1995.
36. Whittle, B. J. R., F. László, S. M. Evans, and S. Moncada. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br. J. Pharmacol. 116: 2286-2290, 1995.
37. Wolf, M. B., D. R. C. Scott II, and P. D. Watson. Microvascular permeability transients due to histamine in cat limb. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H220-H228, 1991.
38. Wu, N. Z., and A. L. Baldwin. Possible mechanism(s) for permeability recovery of venules during histamine application. Microvasc. Res. 44: 334-352, 1992.